Keywords: Sanofi Pasteur, Sanoif, CureVac, Vaccines, Infectious diseases, Pathogens

Sanofi Pasteur and CureVac collaborate on a $33.1 million project on vaccines for infectious diseases

Article | 16 November 2011

Print This

Germany’s CureVac says it has signed several agreements with Sanofi Pasteur, the vaccines division of French drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in